Ladenburg Thalmann Starts Calidi Biotherapeutics Inc (CLDI) at Buy
Tweet
Share
E-mailGet Alerts CLDI Hot Sheet
Price: $1.57 +1.95%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Calidi Biotherapeutics Inc (NYSE: CLDI) with a Buy rating and a price target of $1.00.
For an analyst ratings summary and ratings history on Calidi Biotherapeutics Inc click here. For more ratings news on Calidi Biotherapeutics Inc click here.
Shares of Calidi Biotherapeutics Inc closed at $0.20 yesterday.
You May Also Be Interested In
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
- Leerink Starts Ligand Pharma (LGND) at Outperform
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
